pharmaphorum2d
After FDA snub, DBV charts a new course for Viaskin peanut
It’s been more than three years since DBV Technologies’ peanuty allergy therapy was rejected for FDA approval ... held back by a complicated billing process that held back access, as well ...
Takeda: Buy Into Future Drug Pipeline Potential, Despite Recent Profit Headwinds
Takeda Pharmaceutical has a robust drug discovery pipeline to meet future clinical demand. Check out the upside and downside ...
4 charged in death of 5-year-old boy 'incinerated' in hyperbaric chamber explosion
His mother was standing next to the hyperbaric chamber and suffered injuries to her arms when it exploded Jan. 31 at the ...
4 charged in burning death of 5-year-old
Four people have been charged in the death of a 5-year-old boy who was "incinerated" inside a pressurized oxygen chamber that ...
Top 10 Stocks Wall Street is Discussing
Bill Strazzullo, Bell Curve Trading chief market strategist, said in a latest program on CNBC that the market rally that ...
The American Journal of Managed Care1d
As Claims Denials Surge, AI and Data-Driven Insights Equip Clinicians, Hospitals to Fight Back
As health care costs continue to rise and the burden of chronic disease grows, data-driven insights will be essential in ...
Four charged in death of boy, 5, in medical center blast
A single spark it appears ignited into a fully involved fire that claimed Thomas’s life within seconds,” Attorney General ...
4 charged in death of 5-year-old boy in hyperbaric chamber explosion
Four people have been charged in the death of a 5-year-old boy who was killed inside a pressurized oxygen chamber.
Medpage Today on MSN2d
Four Charged in Death of Young Boy 'Incinerated' in Hyperbaric Chamber Explosion
Four people have been charged in the death of a 5-year-old boy who was "incinerated" inside a pressurized oxygen chamber that exploded at a suburban Detroit medical facility, Michigan's attorney ...